During heart failure, elevated levels of NE in the blood activated PKA and lead to hyperphosphorylation of CaV1.2, which further enhanced Ca2+ induced Ca2+ release through CaV1.2 and RyR2, and resulted in a significant decrease in SERCA2a protein and activity [39, 40]. The gene discussed is CACNA1C; the disease is heart failure.